Esperion Therapeutics
ESPR
#7604
Rank
$0.30 B
Marketcap
$1.52
Share price
1.33%
Change (1 day)
-30.59%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of March 2025 (TTM): 1.04

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.8287. At the end of 2024 the company had a P/S ratio of 1.12.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.12-61.82%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.55 531.20%๐Ÿ‡บ๐Ÿ‡ธ USA
4.83 364.79%๐Ÿ‡บ๐Ÿ‡ธ USA
2.43 133.61%๐Ÿ‡บ๐Ÿ‡ธ USA
5.29 409.02%๐Ÿ‡บ๐Ÿ‡ธ USA
5.17 397.91%๐Ÿ‡บ๐Ÿ‡ธ USA
25.2 2,330.77%๐Ÿ‡บ๐Ÿ‡ธ USA